CRH (NYSE: CRH), a prominent building materials provider, has entered into an agreement to acquire all outstanding shares of Arcosa, Inc. (NYSE: ACA) in an all-cash transaction valued at $150 per share. This deal, subject to Arcosa stockholders' and regulatory approvals, represents a 25% premium to Arcosa's 60-day volume-weighted average price as of June 18, 2026. The total enterprise value of Arcosa is approximately $8.5 billion, which translates to an acquisition multiple of 11.5x Arcosa's estimated 2026 Adjusted EBITDA, including projected annual run-rate cost synergies of $175 million by the third year post-acquisition.

The acquisition significantly strengthens CRH's position as the leading infrastructure player in North America and reinforces its global leadership in US aggregates. Arcosa, headquartered in Dallas, Texas, brings 35 million tons of annual, high-quality, natural, and recycled aggregates, serving 13 of the 50 largest US Metropolitan Statistical Areas (MSAs), including Texas, New Jersey, Arizona, Florida, and Tennessee. This transaction will increase CRH's combined annualized production to over 265 million tons. Additionally, Arcosa's Engineered Structures business holds a top-three market position, benefiting from infrastructure megatrends such as grid modernization, electrification, and data center construction.

CRH views this acquisition as highly complementary to its existing business, advancing its strategy to build an aggregates-led, connected portfolio aligned with growing infrastructure megatrends. The deal is expected to be accretive to CRH's earnings, margin, and cash flow within the first 12 months following completion. Arcosa reported revenues of $2.9 billion in 2025 with a net income of $208 million, and this acquisition deepens CRH's exposure to the US market, which is already the primary driver of its revenue and profits. CRH's CEO, Jim Mintern, stated that this transaction positions CRH at the forefront of immense growth opportunities in US energy and utility infrastructure solutions.